Display of wasp venom allergens on the cell surface of Saccharomyces cerevisiae

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Borodina, Irina ^a   Jensen, Bettina M ^b   Søndergaard, Ib ^a   Poulsen, Lars K ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HISTAMINE; HYALURONIDASE; IMMUNOGLOBULIN E ANTIBODY; MANNOSE OLIGOSACCHARIDE; PHOSPHOLIPASE A1; WASP VENOM; AGA2 PROTEIN, S CEREVISIAE; CELL ADHESION MOLECULE; HYALURONOGLUCOSAMINIDASE; IMMUNOGLOBULIN E; SACCHAROMYCES CEREVISIAE PROTEIN; WHITE FACED HORNET VENOM ANTIGEN 5; WHITE-FACED HORNET VENOM ANTIGEN 5;

ALLERGENICITY; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BASOPHIL; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGUS GROWTH; HISTAMINE RELEASE; HUMAN; HUMAN CELL; INSECT ALLERGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; YEAST CELL; CELL WALL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM;

SACCHAROMYCES CEREVISIAE; VESPULA VULGARIS;

ALLERGENS; BASOPHILS; CELL ADHESION MOLECULES; CELL WALL; FLOW CYTOMETRY; HISTAMINE; HUMANS; HYALURONOGLUCOSAMINIDASE; IMMUNOGLOBULIN E; PHOSPHOLIPASES A1; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; WASP VENOMS;

EID: 77956931340     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-74     Document Type: Article

References (38)

1. Egger M, Hauser M, Himly M, Wopfner N, Wallner M, Ferreira F. Development of recombinant allergens for diagnosis and therapy. Front Biosci (Elite Ed) 2009, 1:77-90.
2. Vrtala S. From allergen genes to new forms of allergy diagnosis and treatment. Allergy 2008, 63(3):299-309. 10.1111/j.1398-9995.2007.01609.x, 18269675.
3. Crameri R, Walter G. Selective enrichment and high-throughput screening of phage surface-displayed cDNA libraries from complex allergenic systems. Comb Chem High Throughput Screen 1999, 2(2):63-72.
4. Edwards MR, Collins AM, Ward RL. The application of phage display in allergy research: characterization of IgE, identification of allergens and development of novel therapeutics. Curr Pharm Biotechnol 2001, 2(3):225-240. 10.2174/1389201013378653, 11530877.
5. Bowley DR, Labrijn AF, Zwick MB, Burton DR. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng Des Sel 2007, 20(2):81-90. 10.1093/protein/gzl057, 17242026.
6. Wadle A, Mischo A, Imig J, Wullner B, Hensel D, Watzig K, Neumann F, Kubuschok B, Schmidt W, Old LJ, et al. Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library. Int J Cancer 2005, 117(1):104-113. 10.1002/ijc.21147, 15880534.
7. Kondo A, Ueda M. Yeast cell-surface display--applications of molecular display. Appl Microbiol Biotechnol 2004, 64(1):28-40. 10.1007/s00253-003-1492-3, 14716465.
8. Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007, 142(2):99-115. 10.1159/000096114, 17033195.
9. Kochuyt AM, Van Hoeyveld EM, Stevens EA. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms. Clin Exp Allergy 2005, 35(4):441-447. 10.1111/j.1365-2222.2005.02217.x, 15836751.
10. van der Veen MJ, van Ree R, Aalberse RC, Akkerdaas J, Koppelman SJ, Jansen HM, van der Zee JS. Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins. J Allergy Clin Immunol 1997, 100(3):327-334. 10.1016/S0091-6749(97)70245-8, 9314344.
11. Ballmer-Weber BK, Wuthrich B, Wangorsch A, Fotisch K, Altmann F, Vieths S. Carrot allergy: double-blinded, placebo-controlled food challenge and identification of allergens. J Allergy Clin Immunol 2001, 108(2):301-307. 10.1067/mai.2001.116430, 11496252.
12. Luttkopf D, Ballmer-Weber BK, Wuthrich B, Vieths S. Celery allergens in patients with positive double-blind placebo-controlled food challenge. J Allergy Clin Immunol 2000, 106(2):390-399. 10.1067/mai.2000.108711, 10932086.
13. Mittermann I, Zidarn M, Silar M, Markovic-Housley Z, Aberer W, Korosec P, Kosnik M, Valenta R. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol 2010, 125(6):1300-1307. e1303, 10.1016/j.jaci.2010.03.017, 20466415.
14. Golden DB. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 2005, 115(3):439-447. quiz 448, 10.1016/j.jaci.2005.01.005, 15753884.
15. Muller UR. New developments in the diagnosis and treatment of hymenoptera venom allergy. Int Arch Allergy Immunol 2001, 124(4):447-453. 10.1159/000053779, 11340327.
16. de Graaf DC, Aerts M, Danneels E, Devreese B. Bee, wasp and ant venomics pave the way for a component-resolved diagnosis of sting allergy. J Proteomics 2009, 72(2):145-154. 10.1016/j.jprot.2009.01.017, 19344653.
17. Hoffman DR, Jacobson RS. Allergens in hymenoptera venom XII: how much protein is in a sting?. Ann Allergy 1984, 52(4):276-278.
18. King TP, Alagon AC, Kuan J, Sobotka AK, Lichtenstein LM. Immunochemical studies of yellowjacket venom proteins. Mol Immunol 1983, 20(3):297-308. 10.1016/0161-5890(83)90069-X, 6865952.
19. Müller UR. Recombinant Hymenoptera venom allergens. Allergy 2002, 57(7):570-576. 10.1034/j.1398-9995.2002.02157.x, 12100296.
20. Kolarich D, Léonard R, Hemmer W, Altmann F. The N-glycans of yellow jacket venom hyaluronidase and the protein sequence of its major isoform in Vespular vulgaris. FEBS J 2005, 272(20):5182-5190. 10.1111/j.1742-4658.2005.04841.x, 16218950.
21. King TP, Lu G, Gonzalez M, Qian N, Soldatova L. Yellow jacket venom allergens, hyaluronidase and phospholipase: sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy. J Allergy Clin Immunol 1996, 98(3):588-600. 10.1016/S0091-6749(96)70093-3, 8828537.
22. Kischnick S, Weber B, Verdino P, Keller W, Sanders EA, Anspach FB, Fiebig H, Cromwell O, Suck R. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies. Protein Expr Purif 2006, 47(2):621-628. 10.1016/j.pep.2006.01.009, 16495080.
23. Monsalve RI, Lu G, King TP. Expressions of recombinant venom allergen, antigen 5 of yellowjacket (Vespula vulgaris) and paper wasp (Polistes annularis), in bacteria or yeast. Protein Expr Purif 1999, 16(3):410-416. 10.1006/prep.1999.1082, 10425162.
24. Skov LK, Seppala U, Coen JJ, Crickmore N, King TP, Monsalve R, Kastrup JS, Spangfort MD, Gajhede M. Structure of recombinant Ves v 2 at 2.0 Angstrom resolution: structural analysis of an allergenic hyaluronidase from wasp venom. Acta Crystallogr D Biol Crystallogr 2006, 62(6):595-604. 10.1107/S0907444906010687, 16699186.
25. Kolarich D, Loos A, Leonard R, Mach L, Marzban G, Hemmer W, Altmann F. A proteomic study of the major allergens from yellow jacket venoms. Proteomics 2007, 7(10):1615-1623. 10.1002/pmic.200600800, 17443842.
26. Seismann H, Blank S, Cifuentes L, Braren I, Bredehorst R, Grunwald T, Ollert M, Spillner E. Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity. Clin Mol Allergy 2010, 8:7. 10.1186/1476-7961-8-7, 2867971, 20359368.
27. Hoffman DR. Allergens in Hymenoptera venom. XXV: The amino acid sequences of antigen 5 molecules and the structural basis of antigenic cross-reactivity. J Allergy Clin Immunol 1993, 92(5):707-716. 10.1016/0091-6749(93)90014-7, 8227862.
28. Hoffman DR. Allergens in hymenoptera venom. XXVI: The complete amino acid sequences of two vespid venom phospholipases. Int Arch Allergy Immunol 1994, 104(2):184-190. 10.1159/000236728, 8199462.
29. Soldatova L, Kochoumian L, King TP. Sequence similarity of a hornet (D. maculata) venom allergen phospholipase A1 with mammalian lipases. FEBS Lett 1993, 320(2):145-149. 10.1016/0014-5793(93)80080-E, 8458431.
30. Mattanovich D, Gasser B, Hohenblum H, Sauer M. Stress in recombinant protein producing yeasts. J Biotechnol 2004, 113(1-3):121-135. 10.1016/j.jbiotec.2004.04.035, 15380652.
31. Huang D, Gore PR, Shusta EV. Increasing yeast secretion of heterologous proteins by regulating expression rates and post-secretory loss. Biotechnol Bioeng 2008, 101(6):1264-1275. 10.1002/bit.22019, 18781684.
32. Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 1997, 15:553-557. 10.1038/nbt0697-553, 9181578.
33. Sørensen HP. Towards universal systems for recombinant gene expression. Microb Cell Fact 2010, 30:9-27.
34. Ballou CE. Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects. Methods Enzymol 1990, 185:440-470. full_text, 2199792.
35. Seppala U, Selby D, Monsalve R, King TP, Ebner C, Roepstorff P, Bohle B. Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition. Mol Immunol 2009, 46(10):2014-2021. 10.1016/j.molimm.2009.03.005, 19375166.
36. Chao G, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display. Nat Protoc 2006, 1(2):755-768. 10.1038/nprot.2006.94, 17406305.
37. Stahl Skov P, Norn S, Weeke B. A new method for detecting histamine release. Agents Actions 1984, 14(3-4):414-416. 10.1007/BF01973840, 6203360.
38. Dorfman A, . (ed) Methods in Enzymology. 1955, Academic Press, Inc., New York, (ed).